Alyce M. Girardi, MD; Leslie R. Pyenson, MD; Jon Morris, PhD; Francis X. Brickfield, MD
Girardi AM, Pyenson LR, Morris J, Brickfield FX. Impact of Coronary Heart Disease on World Leaders. Ann Intern Med. 2001;134:287-290. doi: 10.7326/0003-4819-134-4-200102200-00012
Download citation file:
Published: Ann Intern Med. 2001;134(4):287-290.
Previous studies have shown that from 1965 to 1996, coronary heart disease was a frequent natural cause of death among world leaders.
To assess incidence of and death from coronary heart disease among world leaders and to determine the effect of this disease on office-holding ability.
Archive search of worldwide English-language and translated press and media reports from 1970 to 1999 for reference to coronary events.
U.S. federal government medical analytic unit.
National principal decision makers in countries with populations greater than 250 000.
Reports of angina, heart attack, myocardial infarction, and arrhythmia attributed to coronary artery disease; use of cardiac procedures; receipt of foreign care; death; and removal from office.
64 leaders had initial coronary heart disease events while holding their nation's highest office. Initial event rates decreased from the 1970s to the 1990s (1.9 events per 100 person-years vs. 1.1 events per 100 person-years). Survival, use of procedures, and receipt of foreign care increased over time. Most leaders who survived an acute event continued to function in office.
Incidence of and death from coronary heart disease among office-holding world leaders has decreased over the past 30 years, possibly because of increased use of cardiac procedures. A coronary event in a world leader is unlikely to presage a change in government.
Data collection ended on 1 January 2000. At that time, 17 of 18 members of the 1990–1999 cohort were still alive. The mean survival time was 3 years for the 1970–1979 cohort, 5 years for the 1980–1989 cohort, and at least 4 years for the 1990–1999 cohort. Statistical tests of the differences between cohorts were not performed. Censored data points represent participants who were alive on 1 January 2000; >1 circle or square at a time point indicates ≥ 2 surviving participants.
The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.
Cardiology, Coronary Heart Disease.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only